Interview with Olivier Daubry, General Manager, Celgene France
In only four years Celgene has introduced a number of important products in the French market and is now seen as a…
Celgene France
Last updated: 13.02.2014
Address: 16/18, Rue du Quatre Septembre
75002 Paris
,France
Tel: +33 1 53 42 43 00
Company description
Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide.
Celgene seeks to deliver truly innovative and life-changing drugs for our patients. It’s mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
Thanks to the establishment of its structure in France, a 100% subsidiary of Celgene Corporation, Celgene France ensures its presence on the French health market. Celgene France, besides the marketing of drugs, will establish many clinical trials of new molecules derived from the R&D of Celgene. These, of course, will be conducted in cooperation with the most recognized French medical institutions.
Products and services
There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin’s lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer.
Global Products
ISTODAX® (romidepsin) for injection
REVLIMID® (lenalidomide)
THALOMID® (thalidomide)
VIDAZA® (azacitidine for injection)
Services
LifebankUSA (placental and cord blood banking)
Interviews
Related
David Lescuyer – Managing Director, Skyepharma, France
David Lescuyer, managing director of Skyepharma, a specialized CDMO, reflects on the past three years of the…
Marc-Alexander Burmeister – President, B Braun France
Dr Marc-Alexander Burmeister, president of B Braun in France, shares the exciting changes to come for B Braun…
Françoise Alliot-Launois – Vice President, AFLAR, France
Françoise Alliot-Launois, VP of the French League Against Rheumatism (AFLAR), discusses the issues around bone and…
Finn Søndergaard – CEO, Intsel Chimos, France
Finn Søndergaard, CEO of Intsel Chimos, shares the motivation behind the company’s two recent acquisitions of…
Pierre-Claude Fumoleau – General Manager, AbbVie France
Abbvie France’s Pierre-Claude Fumoleau outlines his strategic priorities for the affiliate, AbbVie’s unique…
Denis Delval – CEO, LFB, France
Denis Delval, CEO of iconic French pharma firm LFB since December 2017, discusses his key priorities to build the…
Olivier Samama – General Manager, France & Head of Sales,…
Biotest’s Olivier Samama outlines the changes that the takeover of the company has had on the French affiliate,…
Edouard Bieth – Managing Director, Tillotts Pharma France
Edouard Bieth, managing director of Tillotts Pharma in France, discusses the opportunities and challenges of…
Government Sector Organisations: France
The healthcare and life sciences industries, as they become more advanced and complex, increasingly require…
Arnaud Gobet – President, Innothera, France
Arnaud Gobet, president of Innothera, discusses how the company balances its unique and diverse offering of medical…
Josephine Yang Comiskey – President, GSK France
Josephine Yang Comiskey, president of GSK France, gives insights into GSK’s corporate culture, portfolio and…
Pierre Banzet – CEO, Groupe SYNERLAB, France
Pierre Banzet, CEO of French CDMO Groupe SYNERLAB, shares how the group has developed over the past three years and…
